Insurance correlates with improved access to care and outcome among glioblastoma patients.

ABSTRACT:

Background

The current standard of care for glioblastoma (GBM) constitutes maximal safe surgical resection, followed by fractionated radiation and temozolomide. This treatment regimen is logistically burdensome, and in a health care system in which access to care is variable, there may be patients with worsened outcomes due to inadequate access to optimal treatment.

Methods

The National Cancer Database was queried for patients with diagnoses of GBM in 2006-2014. Patients were grouped according to insurance status: private insurance, Medicare, Medicaid, or uninsured. Treatments provided (surgery, radiation, and chemotherapy) were compared between groups in univariate and multivariable logistic regression analysis.

Results

A total of 61614 patients were analyzed. Compar

SUBMITTER: Brown DA 

PROVIDER: S-EPMC6120360 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature